Grifols announces phase 3 progress for Albutein
Therapy has the potential to decrease mortality rates in patients with decompensated cirrhosis
Read More
Tag: albutein
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
